Loading data
IVVDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 53.43 m USD | 25.38 m USD | 0 USD | — | — |
| Research and development expense | 38.31 m USD | 137.25 m USD | 158.66 m USD | 179.21 m USD | 182.89 m USD |
| Selling, general and administrative expense | 66.93 m USD | 63.39 m USD | 49.13 m USD | 47.04 m USD | 36.52 m USD |
| Operating profit | -55.56 m USD | -176.88 m USD | -212.76 m USD | -248.03 m USD | -226.91 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -52.5 m USD | -169.93 m USD | -198.64 m USD | -241.32 m USD | -226.79 m USD |
| Basic earnings per share | -0.3 USD/share | -1.43 USD/share | -1.81 USD/share | -2.23 USD/share | -5.32 USD/share |
| Diluted earnings per share | -0.3 USD/share | -1.43 USD/share | -1.81 USD/share | -2.23 USD/share | -5.32 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.